China Testing New ADR Monitoring System Nationwide
This article was originally published in PharmAsia News
Executive Summary
China’s national center for ADR monitoring recently revealed that the next-generation national adverse drug reactions monitoring system has passed preliminary tests and is now being tested nationwide.